The capsid is the structure that protects the virus’s RNA from its surroundings. Most changes in the capsid protein may stop HIV from entering cells. The first capsid-based HIV inhibitor in history, lenacapavir, is injected beneath the skin of the abdomen once every six months to create a slow-release reservoir that delivers the drug into the bloodstream gradually.
